Hikma Pharmaceuticals Share News (HIK)

UK Dividends Calendar - Week Ahead

UK Dividends Calendar - Week Ahead

Sector movers: Astrazeneca boosts pharma stocks on Pfizer return hopes

Astrazenca was leading the pharmaceuticals sector higher on Thursday on the back of speculation that US drug giant Pfizer could return with a fresh offer in the coming days. The reports lifted others in the sector higher in afternoon trading with peers such as Glaxosmithkline, Hikma and BTG making

UK Dividends Calendar - Week Ahead

London midday: UK stocks advance as investors shrug off weak data

- Mining stocks fall as Chinese data weakens - Eurozone PMIs and UK retail sales disappoint - US data, Jackson Hole ahead techMARK 2,810.76 +0.50% FTSE 100 6,772.04 +0.25% FTSE 250 15,797.15 +0.31% Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursda

UK BROKER RATINGS: S&P Capital IQ Cuts Legal & General To Sell

UK Dividends Calendar - Week Ahead

UK Dividends Calendar - Week Ahead

FTSE 250 movers: Ex-divi stocks and Balfour lead index lower

Berkeley Group, Fidessa Group and Taylor Wimpey all dropped into the red after going ex-dividend on Wednesday. Balfour Beatty was in negative territory after rejecting another merger offer from rival Carillion, saying such a move would not be in shareholders' best interest. Tuesday's offer was the

UK MIDDAY BRIEFING: Glencore Rises After Raising Payouts

TOP NEWS: Two Rate Setters Back Rate Rise, BOE Minutes Show

UPDATE 2-Hikma Pharma cuts revenue forecast for branded drugs

* First-half revenue rises 16 pct to $738 mln * Revenue in injectibles business rises 41 pct to $346 mln * Company to pay special dividend of 4 pence per share * Cuts revenue growth forecast for branded drugs business * Shares fall as much as 2.3 percent (Adds CFO, analy

Hikma revenue lifted by strong injectables performance

A strong performance by its injectables business helped drive first half revenue growth of 16% at pharmaceuticals manufacturer Hikma. The business delivered a 41% jump in turnover, lifting group revenue from $638m to $738m and the gross margin from 55.3% to 59.8%. A good performance was seen acr

UK MORNING BRIEFING: Glencore Sets USD1 Billion Share Buyback

CORRECT: Hikma Pharmaceuticals Reiterates Guidance, Declares Special Dividend